 |
114 Diseases |  |
151 Trials |
|
151 Trials |  |
5480 News |  |
| «12...156157158159160161162163164165166167168» |
- doxycycline / Generic mfg.
Trial initiation date: Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma (clinicaltrials.gov) - Aug 11, 2016
P2, N=20, Not yet recruiting, Sponsor: Rochester General Hospital
Initiation date: Jun 2016 --> Sep 2016
- Enrollment change, Trial termination, Trial primary completion date: Use of the Ulcerative Colitis Diet for Induction of Remission (clinicaltrials.gov) - Aug 11, 2016
P=N/A, N=9, Terminated, Sponsor: Prof. Arie Levine
Initiation date: Jun 2016 --> Sep 2016 N=20 --> 9 | Recruiting --> Terminated | Trial primary completion date: Dec 2016 --> Dec 2015; We have submitted a multi center study, with the same nutritional therapy
- | doxycycline / Generic mfg.
Trial completion: Effects of Long Term Antibiotic Therapy on Exacerbation Rate in Stable COPD Patients (clinicaltrials.gov) - Aug 10, 2016
P3, N=222, Completed, Sponsor: Imperial College London
N=20 --> 9 | Recruiting --> Terminated | Trial primary completion date: Dec 2016 --> Dec 2015; We have submitted a multi center study, with the same nutritional therapy Recruiting --> Completed
- | doxycycline / Generic mfg.
New P2 trial: Doxycycline for the Treatment of Nodding Syndrome (clinicaltrials.gov) - Aug 1, 2016
P2, N=230, Not yet recruiting, Sponsor: Makerere University
- doxycycline / Generic mfg.
Enrollment closed: IELSG39: Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment (clinicaltrials.gov) - Jul 28, 2016
P2, N=34, Active, not recruiting, Sponsor: International Extranodal Lymphoma Study Group (IELSG)
Recruiting --> Completed Recruiting --> Active, not recruiting
- doxycycline / Generic mfg.
New P4 trial: DuDHS: Tenofovir/Emtricitabine With Doxycycline for Combination HIV and Syphilis Pre-exposure Prophylaxis in HIV-negative MSM (clinicaltrials.gov) - Jul 27, 2016
P4, N=50, Not yet recruiting, Sponsor: British Columbia Centre for Disease Control
- doxycycline / Generic mfg.
New trial: The Effect of Non-surgical Periodontal Therapy Plus Doxycycline on HbA1c in Patients With Type 2 Diabetes Mellitus (clinicaltrials.gov) - Jul 27, 2016
P=N/A, N=24, Active, not recruiting, Sponsor: Islamic Azad University, Tehran
- Erbitux (cetuximab) / Eli Lilly, EMD Serono, Vectibix (panitumumab) / Amgen, Takeda
Enrollment closed, Metastases: Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab (clinicaltrials.gov) - Jul 23, 2016
P2, N=19, Active, not recruiting, Sponsor: Academic and Community Cancer Research United
Recruiting --> Active, not recruiting Completed --> Active, not recruiting
- Erbitux (cetuximab) / Eli Lilly, EMD Serono, Vectibix (panitumumab) / Amgen, Takeda
Trial completion, Enrollment change, Metastases: Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab (clinicaltrials.gov) - Jul 21, 2016
P2, N=19, Completed, Sponsor: Academic and Community Cancer Research United
Completed --> Active, not recruiting Active, not recruiting --> Completed | N=80 --> 19
- prednisone / Generic mfg., doxycycline / Generic mfg.
New trial, Adverse events: EDP-PB: Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid (clinicaltrials.gov) - Jul 20, 2016
P=N/A, N=150, Recruiting, Sponsor: CHU de Reims
- New trial: PNLABXPART2: Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2 (clinicaltrials.gov) - Jul 12, 2016
P=N/A, N=330, Recruiting, Sponsor: University of California, San Diego
- doxycycline / Generic mfg., azithromycin / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Duration of Antibiotic Therapy as Part of Maximal Medical Therapy for Chronic Rhinosinusitis (clinicaltrials.gov) - Jun 10, 2016
P4, N=37, Completed, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Completed | N=80 --> 19 Recruiting --> Completed | N=100 --> 37 | Trial primary completion date: Apr 2013 --> Jun 2014
- doxycycline / Generic mfg.
Enrollment open, Trial primary completion date: Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease (clinicaltrials.gov) - May 19, 2016
P2, N=50, Recruiting, Sponsor: Hawaii Pacific Health
Recruiting --> Completed | N=100 --> 37 | Trial primary completion date: Apr 2013 --> Jun 2014 Not yet recruiting --> Recruiting | Trial primary completion date: Oct 2015 --> Aug 2016
- doxycycline / Generic mfg.
New P2 trial, IO biomarker: Doxycycline in Human Pulmonary Tuberculosis (clinicaltrials.gov) - May 18, 2016
P2, N=40, Recruiting, Sponsor: National University Hospital, Singapore
- ceftriaxone / Generic mfg., doxycycline / Generic mfg.
Enrollment closed, Enrollment change, Trial primary completion date: Antibiotic Treatment of Multiple Erythema Migrans (clinicaltrials.gov) - May 13, 2016
P=N/A, N=500, Active, not recruiting, Sponsor: University Medical Centre Ljubljana
Not yet recruiting --> Recruiting | Trial primary completion date: Oct 2015 --> Aug 2016 Recruiting --> Active, not recruiting | N=720 --> 500 | Trial primary completion date: Oct 2015 --> Oct 2016
- Trial primary completion date: Cytokines and Chemokines in Erythema Migrans (clinicaltrials.gov) - May 13, 2016
P=N/A, N=150, Recruiting, Sponsor: University Medical Centre Ljubljana
Recruiting --> Active, not recruiting | N=720 --> 500 | Trial primary completion date: Oct 2015 --> Oct 2016 Trial primary completion date: Dec 2015 --> Dec 2017
- doxycycline / Generic mfg., ursodeoxycholic acid / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis (clinicaltrials.gov) - May 13, 2016
P2, N=55, Completed, Sponsor: Umeå University
Trial primary completion date: Dec 2015 --> Dec 2017 Active, not recruiting --> Completed | N=30 --> 55 | Trial primary completion date: Dec 2015 --> Dec 2014
- doxycycline / Generic mfg.
Trial primary completion date: Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA) (clinicaltrials.gov) - May 9, 2016
P2/3, N=286, Recruiting, Sponsor: Paul Yates, MD, PhD
Active, not recruiting --> Completed | N=30 --> 55 | Trial primary completion date: Dec 2015 --> Dec 2014 Trial primary completion date: Jul 2017 --> Jul 2018
- || trimethoprim/sulfamethoxazole / Generic mfg., doxycycline / Generic mfg.
New P3 trial: CleanUp-IPF: CleanUP IPF for the Pulmonary Trials Cooperative (clinicaltrials.gov) - May 3, 2016
P3, N=500, Not yet recruiting, Sponsor: Weill Medical College of Cornell University
- doxycycline / Generic mfg., azithromycin / Generic mfg.
New trial: A Randomized Controlled Trial of Three Antibiotic Regimens for First Trimester Abortions (clinicaltrials.gov) - May 2, 2016
P=N/A, N=180, Recruiting, Sponsor: Medstar Research Institute
- methylprednisolone oral / Generic mfg., doxycycline / Generic mfg.
Clinical: Doxycycline in Treating Patients With Chronic Rhinosinusitis With Nasal Polyps (clinicaltrials.gov) - Apr 27, 2016
P=N/A, N=90, Recruiting, Sponsor: Icahn School of Medicine at Mount Sinai
Trial primary completion date: Jul 2017 --> Jul 2018 Trial primary completion date: May 2016 --> Aug 2016
- doxycycline / Generic mfg.
New P4 trial: Extraction Socket Management Using Connective Tissue Graft Versus Mucograft® (clinicaltrials.gov) - Apr 27, 2016
P4, N=14, Completed, Sponsor: University Hospital of Liege
- doxycycline / Generic mfg.
New P1 trial: ADORE: A Trial of Doxycycline in Renal Disease (clinicaltrials.gov) - Apr 27, 2016
P1, N=20, Recruiting, Sponsor: University of California, San Francisco
- Trial primary completion date: The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID) (clinicaltrials.gov) - Apr 26, 2016
P2, N=233, Completed, Sponsor: Harold Wiesenfeld
Trial primary completion date: May 2016 --> Aug 2016 Trial primary completion date: Mar 2015 --> Aug 2015
- Rabavert (purified chicken-embryo cell rabies vaccine) / Bavarian Nordic
Enrollment open, Trial initiation date, Trial primary completion date: MALRAB: Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis. (clinicaltrials.gov) - Apr 23, 2016
P4, N=100, Recruiting, Sponsor: State University of New York - Upstate Medical University
Trial primary completion date: Mar 2015 --> Aug 2015 Not yet recruiting --> Recruiting | Initiation date: Oct 2015 --> Apr 2016 | Trial primary completion date: Aug 2016 --> Jun 2017
- |||| Vectibix (panitumumab) / Amgen, Takeda
Trial completion, HEOR: Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer (clinicaltrials.gov) - Apr 20, 2016
P2, N=88, Completed, Sponsor: AIO-Studien-gGmbH
Not yet recruiting --> Recruiting | Initiation date: Oct 2015 --> Apr 2016 | Trial primary completion date: Aug 2016 --> Jun 2017 Active, not recruiting --> Completed
- Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%) / Novartis
Trial primary completion date: Manipulating the Microbiome in IBD by Antibiotics and FMT (clinicaltrials.gov) - Apr 15, 2016
P4, N=28, Recruiting, Sponsor: Shaare Zedek Medical Center
Active, not recruiting --> Completed Trial primary completion date: Jun 2016 --> Dec 2016
- doxycycline / Generic mfg.
New P2/3 trial: The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) (clinicaltrials.gov) - Apr 13, 2016
P2/3, N=24, Completed, Sponsor: Amirhossein Farahmand
- doxycycline / Generic mfg.
Enrollment change, Trial initiation date, Trial primary completion date: Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma (clinicaltrials.gov) - Apr 6, 2016
P2, N=20, Not yet recruiting, Sponsor: Rochester General Hospital
Trial primary completion date: Jun 2016 --> Dec 2016 N=40 --> 20 | Initiation date: Sep 2015 --> Jun 2016 | Trial primary completion date: Nov 2016 --> Nov 2017
- doxycycline / Generic mfg.
New P2 trial: Evaluation of Local Doxycycline in Smokers With Chronic Periodontitis (clinicaltrials.gov) - Apr 4, 2016
P2, N=40, Recruiting, Sponsor: University of Campinas, Brazil
- doxycycline / Generic mfg.
Trial completion, Trial primary completion date: Doxycycline in Therapy of Erythema Migrans (clinicaltrials.gov) - Mar 25, 2016
P=N/A, N=400, Completed, Sponsor: University Medical Centre Ljubljana
N=40 --> 20 | Initiation date: Sep 2015 --> Jun 2016 | Trial primary completion date: Nov 2016 --> Nov 2017 Recruiting --> Completed | Trial primary completion date: May 2013 --> Oct 2014
- doxycycline / Generic mfg.
New P1/2 trial: Lipidome and Microbiome Profile of Acne (clinicaltrials.gov) - Mar 21, 2016
P1/2, N=30, Not yet recruiting, Sponsor: University of California, Davis
- nitazoxanide / Generic mfg.
Trial primary completion date: A Two Week Nitazoxanidebased Quadruple Regimen (clinicaltrials.gov) - Mar 10, 2016
P3, N=100, Recruiting, Sponsor: Tanta University
Recruiting --> Completed | Trial primary completion date: May 2013 --> Oct 2014 Trial primary completion date: Jan 2016 --> Sep 2016
- doxycycline / Generic mfg.
Trial primary completion date: Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient Population (clinicaltrials.gov) - Mar 9, 2016
P2, N=40, Recruiting, Sponsor: Ottawa Hospital Research Institute
Trial primary completion date: Jan 2016 --> Sep 2016 Trial primary completion date: Jun 2016 --> Nov 2018
- Trial primary completion date: Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization (clinicaltrials.gov) - Feb 29, 2016
P=N/A, N=200, Recruiting, Sponsor: Horizon Health Network
Trial primary completion date: Jun 2016 --> Nov 2018 Trial primary completion date: Dec 2015 --> Dec 2016
- doxycycline / Generic mfg.
Trial completion, Trial primary completion date, Combination therapy: Safety, Efficacy and Pharmacokinetics of Doxycycline Plus Tauroursodeoxycholic Acid in Transthyretin Amyloidosis (clinicaltrials.gov) - Feb 27, 2016
P2, N=40, Completed, Sponsor: IRCCS Policlinico S. Matteo
Trial primary completion date: Dec 2015 --> Dec 2016 Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Apr 2015
- | bleomycin / Generic mfg., doxycycline / Generic mfg.
Trial completion: Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions (clinicaltrials.gov) - Feb 27, 2016
P3, N=480, Completed, Sponsor: Eastern Cooperative Oncology Group
Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Apr 2015 Active, not recruiting --> Completed
- || Vectibix (panitumumab) / Amgen
Trial primary completion date, Metastases: STEPP: Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy (clinicaltrials.gov) - Feb 23, 2016
P2, N=95, Completed, Sponsor: Amgen
Active, not recruiting --> Completed Trial primary completion date: Oct 2008 --> Jan 2008
- | Erbitux (cetuximab) / Eli Lilly, EMD Serono, Vectibix (panitumumab) / Amgen, Takeda
Trial completion: Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients (clinicaltrials.gov) - Feb 23, 2016
P2, N=24, Completed, Sponsor: Foamix Ltd.
Trial primary completion date: Oct 2008 --> Jan 2008 Active, not recruiting --> Completed
- doxycycline / Generic mfg.
New trial: Does Preoperative Administration of Oral Doxycycline Decrease the Colonization Rate of Propionibacterium Acnes in the Dermis of the Shoulder? (clinicaltrials.gov) - Feb 23, 2016
P=N/A, N=0, Enrolling by invitation, Sponsor: Rothman Institute Orthopaedics
- Erbitux (cetuximab) / Eli Lilly, EMD Serono, Vectibix (panitumumab) / Amgen, Takeda
Trial primary completion date, Metastases: Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab (clinicaltrials.gov) - Feb 13, 2016
P2, N=80, Active, not recruiting, Sponsor: Academic and Community Cancer Research United
Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Jun 2015
- doxycycline / Generic mfg.
New trial: Efficacy of Dead Sea Peloid Gel in Chronic Endometritis (clinicaltrials.gov) - Feb 11, 2016
P=N/A, N=30, Completed, Sponsor: Scientific Center for Family Health and Human Reproduction Problems, Russia
- Trial primary completion date: Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP) (clinicaltrials.gov) - Jan 21, 2016
P2, N=40, Recruiting, Sponsor: Michael Boyle
Trial primary completion date: Dec 2015 --> Jun 2015 Trial primary completion date: Mar 2016 --> Mar 2017
- cephalexin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg., doxycycline / Generic mfg.
Trial primary completion date: Effects of Treatments on Atopic Dermatitis (clinicaltrials.gov) - Dec 29, 2015
P2, N=113, Recruiting, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Mar 2016 --> Mar 2017 Trial primary completion date: Jun 2016 --> Jun 2017
- doxycycline / Generic mfg., amoxicillin / Generic mfg.
Enrollment open: Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis (clinicaltrials.gov) - Dec 23, 2015
P4, N=20, Recruiting, Sponsor: Prof. Arie Levine
Trial primary completion date: Jun 2016 --> Jun 2017 Not yet recruiting --> Recruiting
- doxycycline / Generic mfg.
Enrollment open, Trial initiation date, Trial primary completion date: Scheduled Prophylactic Antiemetics for Reduction of Emesis With Doxycycline (SPARED) Trial (clinicaltrials.gov) - Dec 12, 2015
P=N/A, N=300, Recruiting, Sponsor: University of Rochester
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Initiation date: Jun 2015 --> Oct 2015 | Trial primary completion date: Jun 2017 --> Oct 2017
- Trial completion: The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID) (clinicaltrials.gov) - Dec 5, 2015
P2, N=233, Completed, Sponsor: Harold Wiesenfeld
Not yet recruiting --> Recruiting | Initiation date: Jun 2015 --> Oct 2015 | Trial primary completion date: Jun 2017 --> Oct 2017 Active, not recruiting --> Completed
- doxycycline / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Doxycycline In Lymphangioleiomyomatosis (LAM) (clinicaltrials.gov) - Dec 5, 2015
P4, N=24, Completed, Sponsor: University of Nottingham
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=40 --> 24 | Trial primary completion date: Apr 2013 --> Jan 2013
- | doxycycline / Generic mfg.
Enrollment open, Head-to-Head: Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis (clinicaltrials.gov) - Dec 4, 2015
P3, N=250, Enrolling by invitation, Sponsor: Sorlandet Hospital HF
Active, not recruiting --> Completed | N=40 --> 24 | Trial primary completion date: Apr 2013 --> Jan 2013 Not yet recruiting --> Enrolling by invitation
- || nitazoxanide / Generic mfg.
New P3 trial: A Two Week Nitazoxanidebased Quadruple Regimen (clinicaltrials.gov) - Dec 3, 2015
P3, N=100, Recruiting, Sponsor: Tanta University